Press Releases

Debiopharm Group™ Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty

Spinomix announces a milestone payment from Debiopharm Group™ and the appointment of a new CEO

BPA Solutions get Investment funds to accelerate rapid growth and global expansion

Atheris and Debiopharm Group™ to collaborate for the lead optimization of Debio 0826 using a “Reverse-Discovery” strategy

Curis and Debiopharm Group™ Announce Initiation of Phase I Dose Finding Clinical Study with a Combination of HSP90 Inhibitor Debio…

Experimental Therapeutics Centre and Debiopharm Group™ to collaborate for the development of an epigenetic innovative oncology target

Presented by the Japanese Cancer Association and Debiopharm Group™ the ‘JCA Mauvernay Award 2013’ goes to Doctors Kitabayashi and Yano

Debiopharm Group™ inaugure la « Debiopharm academy » à l’EPFL avec une première conférence sur la médecine personnalisée

Debiopharm Group™ a le plaisir d’annoncer les étudiants choisis pour les Bourses d’excellence